Susan E. Alters

1.4k total citations · 1 hit paper
32 papers, 1.1k citations indexed

About

Susan E. Alters is a scholar working on Genetics, Molecular Biology and Immunology. According to data from OpenAlex, Susan E. Alters has authored 32 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Genetics, 10 papers in Molecular Biology and 10 papers in Immunology. Recurrent topics in Susan E. Alters's work include Virus-based gene therapy research (6 papers), Cancer Research and Treatments (5 papers) and CAR-T cell therapy research (5 papers). Susan E. Alters is often cited by papers focused on Virus-based gene therapy research (6 papers), Cancer Research and Treatments (5 papers) and CAR-T cell therapy research (5 papers). Susan E. Alters collaborates with scholars based in United States, Netherlands and United Kingdom. Susan E. Alters's co-authors include Scott W. Rowlinson, C. Garrison Fathman, George Georgiou, Everett Stone, Peng Huang, Kendra Triplett, Surendar Tadi, Wupeng Yan, Michael J. Keating and John DiGiovanni and has published in prestigious journals such as Nature Medicine, The Journal of Experimental Medicine and Journal of Clinical Oncology.

In The Last Decade

Susan E. Alters

29 papers receiving 1.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Systemic depletion of L-cyst(e)ine with cyst(e)inase increases reactive oxygen species and suppresses tumor growth

2016 431 citations Achinto Saha, Jinyun Liu et al. Nature Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Susan E. Alters United States	14	443	339	233	184	170	32	1.1k
Tatsuhiro Yoshiki Japan	21	550 1.2×	115 0.3×	245 1.1×	314 1.7×	246 1.4×	68	1.3k
Ryuji Maekawa Japan	19	386 0.9×	343 1.0×	347 1.5×	87 0.5×	550 3.2×	51	1.2k
D Glaves United States	19	346 0.8×	228 0.7×	205 0.9×	156 0.8×	381 2.2×	41	988
David A. Sampson United States	12	371 0.8×	126 0.4×	187 0.8×	105 0.6×	254 1.5×	23	1.1k
Masaki Nogawa Japan	19	598 1.3×	108 0.3×	167 0.7×	182 1.0×	467 2.7×	34	1.2k
Shweta Joshi United States	23	655 1.5×	403 1.2×	239 1.0×	119 0.6×	382 2.2×	48	1.5k
Ewa Zając United States	14	528 1.2×	445 1.3×	309 1.3×	104 0.6×	457 2.7×	20	1.2k
Songbo Qiu United States	15	483 1.1×	105 0.3×	271 1.2×	123 0.7×	362 2.1×	26	872
Mark D. Long United States	21	778 1.8×	288 0.8×	358 1.5×	254 1.4×	423 2.5×	70	1.4k
Satoko Okada Japan	21	547 1.2×	137 0.4×	499 2.1×	190 1.0×	287 1.7×	49	1.3k

Countries citing papers authored by Susan E. Alters

Since Specialization

Citations

This map shows the geographic impact of Susan E. Alters's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Susan E. Alters with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Susan E. Alters more than expected).

Fields of papers citing papers by Susan E. Alters

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Susan E. Alters. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Susan E. Alters. The network helps show where Susan E. Alters may publish in the future.

Co-authorship network of co-authors of Susan E. Alters

This figure shows the co-authorship network connecting the top 25 collaborators of Susan E. Alters. A scholar is included among the top collaborators of Susan E. Alters based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Susan E. Alters. Susan E. Alters is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Alters, Susan E., et al.. (2019). Preclinical safety and antitumor activity of the arginine-degrading therapeutic enzyme pegzilarginase, a PEGylated, cobalt-substituted recombinant human arginase 1. Translational research. 217. 11–22. 22 indexed citations

Saha, Achinto, Jinyun Liu, Surendar Tadi, et al.. (2016). Systemic depletion of L-cyst(e)ine with cyst(e)inase increases reactive oxygen species and suppresses tumor growth. Nature Medicine. 23(1). 120–127. 431 indexed citations breakdown →

Alters, Susan E., Jinyun Liu, Peng Huang, et al.. (2016). Development of a Human Therapeutic L-Cyst(e)Ine-Degrading Enzyme for the Treatment of Hematological Malignancies. Blood. 128(22). 1587–1587.

Burrage, Lindsay C., Qin Sun, Sarah H. Elsea, et al.. (2015). Human recombinant arginase enzyme reduces plasma arginine in mouse models of arginase deficiency. Human Molecular Genetics. 24(22). 6417–6427. 38 indexed citations

Cleland, Jeffrey L., Jerome A. Moore, Benjamin Spink, et al.. (2012). A Novel Long-Acting Human Growth Hormone Fusion Protein (VRS-317): Enhanced In Vivo Potency and Half-Life. Journal of Pharmaceutical Sciences. 101(8). 2744–2754. 57 indexed citations

Alters, Susan E., Benjamin Spink, Chia‐Wei Wang, et al.. (2012). GLP2-2G-XTEN: A Pharmaceutical Protein with Improved Serum Half-Life and Efficacy in a Rat Crohn’s Disease Model. PLoS ONE. 7(11). e50630–e50630. 53 indexed citations

Cleland, Jeffrey L., Alvin Wong, & Susan E. Alters. (2005). The targeted cytotoxic prodrug, AQ4N, persists in the spleen, large intestine, and subcutaneous tumors. Cancer Research. 65. 565–565.

Wartchow, Charles, Susan E. Alters, Pamela D. Garzone, et al.. (2004). Enhancement of the Efficacy of An Antagonist of an Extracellular Receptor by Attachment to the Surface of a Biocompatible Carrier. Pharmaceutical Research. 21(10). 1880–1885. 1 indexed citations

Philip, Ramila, et al.. (2000). Dendritic Cells Loaded With MART-1 Peptide or Infected With Adenoviral Construct Are Functionally Equivalent in the Induction of Tumor-Specific Cytotoxic T Lymphocyte Responses in Patients With Melanoma. Journal of Immunotherapy. 23(1). 168–176. 26 indexed citations

10.

Alters, Susan E., et al.. (1999). IL-13 Can Substitute for IL-4 in the Generation of Dendritic Cells for the Induction of Cytotoxic T Lymphocytes and Gene Therapy. Journal of Immunotherapy. 22(3). 229–236. 25 indexed citations

11.

Alters, Susan E., et al.. (1998). Dendritic Cells Pulsed with CEA Peptide Induce CEA-Specific CTL with Restricted TCR Repertoire. Journal of Immunotherapy. 21(1). 17–26. 48 indexed citations

12.

Goldrath, Ananda W., et al.. (1995). Differences in Adhesion Markers, Activation Markers, and TcR in Islet Infiltrating Peripheral Lymphocytes in the NOD Mouse. Journal of Autoimmunity. 8(2). 209–220. 9 indexed citations

13.

Philip, Ramila, Elisa Brunette, Mary Philip, et al.. (1995). Generation of Tumor Specific CTL Using Genetically Modified Antigen Presenting Cells. Journal of Immunotherapy. 18(2). 127–127. 2 indexed citations

14.

Goldrath, Ananda W., et al.. (1995). RETENTION OF ENDOCRINE FUNCTION IN THE SCID-Hu PANCREAS MOUSE—A MODEL FOR THE DEVELOPMENT OF HUMAN FETAL ISLET TISSUE. Transplantation. 59(10). 1497–1500. 6 indexed citations

15.

Song, Howard K., et al.. (1993). EVIDENCE THAT ANTI-CD8 ABROGATES ANTI-CD4-MEDIATED CLONAL ANERGY BUT ALLOWS ALLOGRAFT SURVIVAL IN MICE. Transplantation. 55(1). 133–138. 11 indexed citations

16.

Alters, Susan E., et al.. (1993). EVIDENCE THAT CLONAL ANERGY IS INDUCED IN THYMIC MIGRANT CELLS AFTER ANTI-CD4-MEDIATED TRANSPLANTATION TOLERANCE. Transplantation. 56(3). 633–637. 21 indexed citations

17.

Alters, Susan E., et al.. (1992). Anti‐CD4 Monoclonal Antibodies in Therapy: Creation of Nonclassical Tolerance in the Adult. Immunological Reviews. 129(1). 105–130. 62 indexed citations

18.

Alters, Susan E., et al.. (1991). Anti-CD4 mediates clonal anergy during transplantation tolerance induction.. The Journal of Experimental Medicine. 173(2). 491–494. 82 indexed citations

19.

Alters, Susan E., Keisuke Sakai, Lawrence Steinman, & Vernon T. Oi. (1990). Mechanisms of anti-CD4-mediated depletion and immunotherapy. A study using a set of chimeric anti-CD4 antibodies.. The Journal of Immunology. 144(12). 4587–4592. 38 indexed citations

20.

Alters, Susan E., Lawrence Steinman, & Vernon T. Oi. (1989). Comparison of rat and rat-mouse chimeric anti-murine CD4 antibodies in vitro. Chimeric antibodies lyse low-density CD4+ cells.. The Journal of Immunology. 142(6). 2018–2023. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact